These subjects included anti-Ro antibody-positive mothers who were referred for longitudinal follow-up after giving birth to a child with neonatal lupus or congenital heart block, and healthy controls re-classified to the ANS group following discovery of a positive ANA (≥ 1:160) on laboratory testing. The gene discussed is BTG3; the disease is congenital heart block.